MedWatch

GN Hearing beats analyst expectations for Q1

GN Hearing ended the first quarter of 2022 with an organic growth of 2%, though shipping costs led to a slightly disappointing operating result for the firm. (Updated)

Photo: GN Store Nord / PR

The first three months of the year are behind us, and GN Hearing has now revealed how it fared in the quarter.

The listed hearing aid company ended Q1 with 2% organic growth and a revenue of DKK 1.337bn (USD 190.7m)

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs